A University of Pennsylvania study has demonstrated that a dual-action lipid nanoparticle can reverse T-cell exhaustion and ...
Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...
A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.
Cancer dysregulates the immune response to evade cell death and progress throughout the body. As tumors become established, ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on ...
Morning Overview on MSN
Researchers map real-time signals that trigger T cell activation
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
Sagar Lonial, MD, discusses the expanding potential uses of cereblon E3 ligase modulators (CELMoDs) in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results